Shares of Nanthealth LLC (NYSE:NH) saw unusually-high trading volume on Friday . Approximately 94,852 shares changed hands during trading, an increase of 42% from the previous session’s volume of 67,023 shares.The stock last traded at $11.24 and had previously closed at $10.60.

NH has been the topic of a number of recent analyst reports. FBR & Co reaffirmed a “buy” rating on shares of Nanthealth in a report on Wednesday. Jefferies Group initiated coverage on Nanthealth in a report on Monday, June 27th. They set a “buy” rating on the stock. Canaccord Genuity began coverage on Nanthealth in a report on Monday, June 27th. They set a “buy” rating and a $17.00 price target on the stock. Cowen and Company began coverage on Nanthealth in a report on Monday, June 27th. They set an “outperform” rating and a $19.00 target price on the stock. Finally, First Analysis began coverage on Nanthealth in a report on Monday, June 27th. They set an “overweight” rating and a $18.00 target price on the stock. Five research analysts have rated the stock with a buy rating, The stock presently has an average rating of “Buy” and a consensus target price of $18.00.

The stock’s market cap is $6.40 billion. The company has a 50 day moving average of $11.71 and a 200 day moving average of $12.41.

Nanthealth (NYSE:NH) last announced its quarterly earnings data on Tuesday, August 9th. The company reported ($0.15) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.26. The company had revenue of $31.50 million for the quarter, compared to analyst estimates of $23.55 million. The firm’s quarterly revenue was up 166.9% compared to the same quarter last year. Equities analysts expect that Nanthealth LLC will post ($0.85) EPS for the current year.

In other Nanthealth news, CEO Patrick Soon-Shiong bought 357,143 shares of the stock in a transaction that occurred on Tuesday, June 7th. The shares were acquired at an average price of $14.00 per share, with a total value of $5,000,002.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Healthcare Solution Allscripts bought 714,286 shares of the stock in a transaction that occurred on Tuesday, June 7th. The stock was acquired at an average cost of $14.00 per share, for a total transaction of $10,000,004.00. Following the purchase, the insider now owns 15,000,000 shares of the company’s stock, valued at $210,000,000. The disclosure for this purchase can be found here.

Nant Health, LLC is an evidence-based, personalized healthcare company. The Company’s systems-based approach to personalized healthcare applies diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with real-time biometric signal and phenotypic data to track patient outcomes and deliver medicine.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.